Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study

Adagio Medical Holdings Inc. (NASDAQ:ADGM) is one of the best up and coming penny stocks to buy. On February 4, Adagio Medical Holdings announced the publication of results from its US Early Feasibility Study/EFS evaluating ultralow temperature cardiac ablation/ULTC for treating scar-related ventricular tachycardia.

The multicenter study involved 20 patients with ischemic and non-ischemic cardiomyopathy across four US centers. The research focused on the acute safety and performance of ULTC in individuals with drug-refractory conditions, marking the first published US clinical experience for this technology under the FDA’s EFS framework. The study showed a favorable safety profile with no major adverse events recorded at 7 or 30 days, alongside strong clinical performance.

Among tested patients, 92.9% achieved non-inducibility of the targeted clinical arrhythmia after ablation. At a 24-week follow-up, 72% of patients successfully reduced or discontinued antiarrhythmic medications, and 83.3% remained free from implantable cardioverter-defibrillator shocks. Investigators noted that the technology’s ability to create deep, titratable lesions is particularly effective for treating deep intramural substrates found in challenging patient populations.

Adagio Medical Holdings Inc. (NASDAQ:ADGM) is a developmental-stage medical device company that develops and commercializes ablation technologies for the treatment of cardiac arrhythmias.

While we acknowledge the potential of ADGM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.